Compounded Semaglutide as a BCBS Alternative Without Prior Authorization Patients facing BCBS coverage denials or long prior authorization delays can access compounded semaglutide injection through licensed 503A compounding pharmacies without requiring insurance approval
[ 3 ] Additionally, a study of 2,405 patients found an average weight loss of 2.2% after 72 weeks on GLP-1 medications
Retrieved 15 May 2025
Q: Who can use this product
Patients often choose infusions when they want a longer session, a full drip experience, and a more gradual treatment format instead of a quick shot
Bianchi, G., Bugianesi, E., Ronchi, M., Fabbri, A., Zoli, M., & Marchesini, G